Showing 51–100 of 20,598 genes
| # | Gene | Name | Chr | Tags | PubMed | PubMed Papers |
|---|---|---|---|---|---|---|
| 51 | CXCR4 | C-X-C motif chemokine receptor 4 | 2 | Hub GeneReceptor | 2,177 | 2,177 |
| 52 | IFNG | interferon gamma | 12 | ApoptosisHub Gene | 2,159 | 2,159 |
| 53 | TERT | telomerase reverse transcriptase | 5 | Hub GeneFDA Approved Target | 2,102 | 2,102 |
| 54 | COMT | catechol-O-methyltransferase | 22 | Hub GeneFDA Approved Target | 2,076 | 2,076 |
| 55 | IGF1 | insulin like growth factor 1 | 12 | Hub GeneClinical Trials | 2,076 | 2,076 |
| 56 | CD4 | CD4 molecule | 12 | Hub GeneReceptor | 2,026 | 2,026 |
| 57 | MMP2 | matrix metallopeptidase 2 | 16 | Hub GeneProtease | 1,979 | 1,979 |
| 58 | CFTR | CF transmembrane conductance regulator | 7 | Ion ChannelTransporter | 1,945 | 1,945 |
| 59 | LEP | leptin | 7 | Hub GeneOMIM Disease Gene | 1,912 | 1,912 |
| 60 | NFE2L2 | NFE2 like bZIP transcription factor 2 | 2 | Hub GeneTranscription Factor | 1,912 | 1,912 |
| 61 | GSTT1 | glutathione S-transferase theta 1 | 22 | Highly StudiedExperimental GO Evidence | 1,901 | 1,901 |
| 62 | CDKN1A | cyclin dependent kinase inhibitor 1A | 6 | Hub GeneHighly Studied | 1,844 | 1,844 |
| 63 | SIRT1 | sirtuin 1 | 10 | Hub GeneTranscription Factor | 1,824 | 1,824 |
| 64 | JAK2 | Janus kinase 2 | 9 | ApoptosisHub Gene | 1,812 | 1,812 |
| 65 | CCND1 | cyclin D1 | 11 | Hub GeneOncogene | 1,795 | 1,795 |
| 66 | ACE2 | angiotensin converting enzyme 2 | X | Hub GeneProtease | 1,724 | 1,724 |
| 67 | GSTP1 | glutathione S-transferase pi 1 | 11 | Hub GeneClinical Trials | 1,723 | 1,723 |
| 68 | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 3 | Highly ConstrainedHub Gene | 1,720 | 1,720 |
| 69 | RELA | RELA proto-oncogene, NF-kB subunit | 11 | Hub GeneTranscription Factor | 1,681 | 1,681 |
| 70 | HLA-A | major histocompatibility complex, class I, A | 6 | Hub GeneHighly Studied | 1,676 | 1,676 |
| 71 | IL17A | interleukin 17A | 6 | Hub GeneFDA Approved Target | 1,654 | 1,654 |
| 72 | CCR5 | C-C motif chemokine receptor 5 | 3 | Hub GeneReceptor | 1,643 | 1,643 |
| 73 | CCL2 | C-C motif chemokine ligand 2 | 17 | Hub GeneClinical Trials | 1,641 | 1,641 |
| 74 | TLR2 | toll like receptor 2 | 4 | Hub GeneReceptor | 1,622 | 1,622 |
| 75 | NOTCH1 | notch receptor 1 | 9 | Highly ConstrainedHub Gene | 1,592 | 1,592 |
| 76 | PARP1 | poly(ADP-ribose) polymerase 1 | 1 | ApoptosisDNA Repair | 1,590 | 1,590 |
| 77 | ATM | ATM serine/threonine kinase | 11 | Homologous RecombinationHub Gene | 1,575 | 1,575 |
| 78 | GSK3B | glycogen synthase kinase 3 beta | 3 | Hub GeneKinase | 1,556 | 1,556 |
| 79 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 6 | Highly StudiedTrending | 1,556 | 1,556 |
| 80 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 7 | Highly ConstrainedHub Gene | 1,553 | 1,553 |
| 81 | SERPINE1 | serpin family E member 1 | 7 | Hub GeneEarly Pipeline | 1,549 | 1,549 |
| 82 | YAP1 | Yes1 associated transcriptional regulator | 11 | Highly ConstrainedHub Gene | 1,515 | 1,515 |
| 83 | SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20 | Hub GeneKinase | 1,512 | 1,512 |
| 84 | ITGB1 | integrin subunit beta 1 | 10 | Hub GeneReceptor | 1,502 | 1,502 |
| 85 | HMGB1 | high mobility group box 1 | 13 | DNA RepairHighly Constrained | 1,499 | 1,499 |
| 86 | MAPK3 | mitogen-activated protein kinase 3 | 16 | Hub GeneKinase | 1,495 | 1,495 |
| 87 | F2 | coagulation factor II, thrombin | 11 | Hub GeneProtease | 1,489 | 1,489 |
| 88 | CD44 | CD44 molecule (IN blood group) | 11 | Hub GeneReceptor | 1,488 | 1,488 |
| 89 | CXCL12 | C-X-C motif chemokine ligand 12 | 10 | Hub GeneHighly Studied | 1,470 | 1,470 |
| 90 | MAPK14 | mitogen-activated protein kinase 14 | 6 | Hub GeneKinase | 1,465 | 1,465 |
| 91 | RB1 | RB transcriptional corepressor 1 | 13 | Highly ConstrainedHub Gene | 1,423 | 1,423 |
| 92 | MET | MET proto-oncogene, receptor tyrosine kinase | 7 | Hub GeneKinase | 1,418 | 1,418 |
| 93 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 14 | Hub GeneClinical Trials | 1,403 | 1,403 |
| 94 | EP300 | EP300 lysine acetyltransferase | 22 | ApoptosisHighly Constrained | 1,399 | 1,399 |
| 95 | UBC | ubiquitin C | 12 | Hub GeneHighly Studied | 1,371 | 1,371 |
| 96 | BIRC5 | baculoviral IAP repeat containing 5 | 17 | Hub GeneTranscription Factor | 1,364 | 1,364 |
| 97 | ICAM1 | intercellular adhesion molecule 1 | 19 | Hub GeneReceptor | 1,358 | 1,358 |
| 98 | XRCC1 | X-ray repair cross complementing 1 | 19 | DNA RepairHub Gene | 1,347 | 1,347 |
| 99 | F5 | coagulation factor V | 1 | FDA Approved TargetOMIM Disease Gene | 1,344 | 1,344 |
| 100 | SP1 | Sp1 transcription factor | 12 | Highly ConstrainedHub Gene | 1,341 | 1,341 |